Skip to content
-
Condition:
Factory New
- Weight: 0.13 lb
- Smoking cessation transdermal patch for use after completing Step 2 series of Nicoderm CQ patches
- Nicotine patch helps prevent the urge to smoke and relieves the anxiety, frustration, irritability and restlessness associated with smoking cessation.
- Extended Release SmartControl Technology steadily delivers nicotine all day long to help manage nicotine cravings.
- 7 milligrams of nicotine per patch; 14 patches per box
-
Learn more:
-
MFR:
Glaxo Consumer Products
Ships from MFI Medical
- MPN: 135019602
+Free Shipping*
Shop with Confidence
Free Shipping
Free Returns
Sales Tax Exemption
+Dedicated Account Managers
Frequently asked questions
Is this patch suitable for long-term nicotine delivery?
The Nicoderm CQ patch is designed for controlled delivery over a 24-hour period. It uses patented SmartControl technology to ensure a steady release of nicotine, which helps manage withdrawal symptoms and cravings consistently throughout the day and night.
Does this patch help specifically with severe cravings?
Yes, it is formulated to reduce the physical withdrawal symptoms and nicotine cravings that occur when you stop smoking. By providing a measured dose of nicotine, it helps bridge the gap during the final stage of your cessation journey.
How many patches are provided in each box?
Each box contains 14 clear patches, which provides a convenient 2-week supply to help you stay on track with your quit-smoking plan.
Is this product considered medical-grade quality?
Yes, Nicoderm CQ is a medical-grade smoking cessation aid produced by Glaxo Consumer Products, designed to meet rigorous standards for those committed to transitioning away from tobacco use.
Is this specific strength right for beginners?
The 7 mg patch is intended for the final step of a cessation program. It is specifically designed for users who have already successfully moved through the initial phases (Step 1 and Step 2) and smoke their first cigarette more than 30 minutes after waking.
Are these patches discreet to wear?
Yes, each patch is clear, allowing for a more discreet application while you continue your daily activities throughout the 24-hour wear cycle.
How does the SmartControl technology benefit me?
The SmartControl technology is a patented feature that ensures a steady, controlled release of nicotine. This prevents ‘peaks and valleys’ in your nicotine levels, providing a more stable and manageable experience as you reduce your intake.
Does this support a structured cessation plan?
Absolutely. This patch is a vital component of a proven cessation system. It is intended to be used as the final step in a multi-stage process to help you successfully transition away from cigarettes.
Does the patch provide 24-hour relief from withdrawal?
Yes, each patch is engineered with SmartControl Technology to deliver a steady, consistent release of nicotine over a full 24-hour period. This helps maintain stable nicotine levels, which is vital for managing: <ul><li>Anxiety</li><li>Irritability</li><li>Restlessness</li><li>Physical urges</li></ul>
Is it safe to start the program with this patch?
No, this product is specifically designed as the final step (Step 3) of the Nicoderm CQ program. You should only use these 7 mg patches after you have successfully completed the Step 1 and Step 2 series. Starting with the correct dosage is critical to a safe and effective transition toward a smoke-free life.
Glaxo Consumer Products Nicoderm CQ N...